Key result
Higher peak VO2 was associated with a lower risk of composite adverse events in older patients with heart failure, with the strongest prognostic value observed in those aged 80 years or older (HR 0.72).
Why the study?
The prognostic value of cardiopulmonary exercise testing parameters in patients aged ≥80 years with heart failure remains unclear.
Do cardiopulmonary exercise testing (CPET) parameters predict the composite of all-cause death or heart failure hospitalization in age-stratified patients with heart failure?
Cohort (n=830)
Yes
Do cardiopulmonary exercise testing (CPET) parameters predict the composite of all-cause death or heart failure hospitalization in age-stratified patients with heart failure?
Cardiopulmonary exercise testing parameters, particularly peak VO2, provide robust and age-dependent prognostic value for adverse outcomes in patients with heart failure, including those aged 80 years and older.
Peak VO2 association with lower events in older HF may aid stratification; extends prognostic data to age ≥80 but remains hypothesis-generating.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ogura et al. (2026) conducted a cohort in Heart Failure (n=830). Cardiopulmonary exercise testing parameters (peak VO2 and VE/VCO2 slope) vs. Lower peak VO2 or lower VE/VCO2 slope was evaluated on Composite of all-cause death or HF hospitalization within 3 years (HR 0.72, 95% CI 0.62-0.85, p=<0.001). Higher peak VO2 was associated with a lower risk of composite adverse events in older patients with heart failure, with the strongest prognostic value observed in those aged 80 years or older (HR 0.72).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: